Back

ANGPTL4 as a therapeutic target in coronary artery disease.

27 August 2017 (11:22 - 11:45)
Organised by:
Congress Presentation Part of: Evolving concepts in angiogenesis Angiogenesis ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Stephane Germain

College of France, Paris (France)

3 More presentations in this session

Presentation thumbnail
Transcriptional control of angiogenesis.
Doctor G. Birdsey (London, GB)
Slides Video
Presentation thumbnail
Tissue factor: a promising candidate for therapeutic angiogenesis after ischaemic damage.
Professor L. Badimon (Barcelona, ES)
Presentation thumbnail
Stem cell angiogenesis to repair the damaged heart: the power of cell conditioning.
Professor S. Dimmeler (Frankfurt, DE)

Access the full session

Session thumbnail
Evolving concepts in angiogenesis

The Event

Event poster

ESC Congress 2017

27 August 2017 11:22 CET
You may be interested in
thumbnail
Congress Presentation
RNA interference targeting hepatic angiopoietin-like protein 3 results in prolonged reductions in serum triglyceride and non-HDL cholesterol concentrations: first human results with ARO-ANG3
25 August 2023
thumbnail
Congress Presentation
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis
27 August 2021
thumbnail
Congress Presentation
Angiopoietin-like protein (Angptl) 2 secreted from epicardial adipose tissue induces atrial myocardial fibrosis
1 September 2019
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources